Myocardial Disease in Systemic Sclerosis: Recent Updates and Clinical Implications

Area of Science:

• Cardiology
• Rheumatology
• Immunology

Background:

• Systemic sclerosis (SSc) frequently involves the heart, leading to significant morbidity and mortality.
• Cardiac involvement in SSc is driven by inflammation, microvascular dysfunction, and fibrosis.
• Understanding these mechanisms is crucial for managing SSc-associated myocardial disease.

Purpose of the Study:

• To review the mechanisms of SSc-associated myocardial disease.
• To identify critical risk factors for cardiac involvement in SSc.
• To explore advanced diagnostic tools for early detection and risk stratification.

Main Methods:

• Review of recent literature on SSc-associated myocardial disease.
• Analysis of risk factors including autoantibody profiles, disease duration, and comorbidities.
• Evaluation of advanced imaging techniques and biomarkers for early diagnosis.

Main Results:

• Specific autoantibody profiles, disease duration, and comorbidities are key risk factors.
• Advanced imaging and biomarkers aid in early identification and risk stratification.
• Subclinical myocardial involvement can be detected, potentially preventing symptomatic disease progression.

Conclusions:

• SSc-associated myocardial disease is challenging to predict.
• Novel imaging and biomarker strategies offer promising avenues for early diagnosis and intervention.
• Integrating advanced approaches can enhance screening, mitigate progression, and improve patient outcomes.